Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 7/20 | 0.59 |
| ▸ | NPY4R | P50391 | 7/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.59 |
| ▸ | NPY1R | P25929 | 5/20 | 0.59 |
| ▸ | EP300 | Q09472 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.57 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.57 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.57 |
| ▸ | CALCR | P30988 | 8/20 | 0.57 |
| ▸ | RAMP3 | O60896 | 4/20 | 0.57 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30726569 | 0.91 | RAMP3 (0.63) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL30658199 | 0.90 | NPY2R (0.63) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL29827221 | 0.90 | NPY2R (0.59) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL30262203 | 0.90 | NPY2R (0.59) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL29786933 | 0.90 | RAMP3 (0.57) | NPY2RNPY4RNPY5RNPY1RMAPK8 | |
| SCHEMBL29357279 | 0.90 | NPY2R (0.59) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL29456236 | 0.89 | EP300 (0.53) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL31182614 | 0.89 | MAPK8 (0.61) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL30429252 | 0.89 | NPY2R (0.64) | NPY2RNPY4RNPY5RNPY1REP300 | |
| SCHEMBL30495693 | 0.89 | MAPK8 (0.61) | NPY2RNPY4RNPY5RNPY1REP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240269300-A1 | METHODS OF USING GLYCOPOLYSIALYLATED THERAPEUTIC PROTEINS | XENETIC BIOSCIENCES, INC. (US) | 2024-08-15 | — | — | US | disclosed |